Sexual Functioning in Long-Term Breast Cancer Survivors Treated with Adjuvant Chemotherapy

By Broeckel J.A.  

Breast Cancer Research and Treatment, Vol. 75, Iss. 3, 2002-10 ,pp. : 241-248

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer

By Abe Hajime  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 487-491

Springer Publishing Company

Access to resources Recommend Favorite

Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide

By Andersen Kenneth Geving   Jensen Maj-Britt   Kehlet Henrik   Gärtner Rune   Eckhoff Lise   Kroman Niels  

Acta Oncologica, Vol. 51, Iss. 8, 2012-11 ,pp. : 1036-1044

Informa Healthcare

Access to resources Recommend Favorite

Quality of life after adjuvant chemotherapy for breast cancer

By Broeckel J.A.   Jacobsen P.B.   Balducci L.   Horton J.   Lyman G.H.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 141-150

Springer Publishing Company

Access to resources Recommend Favorite

Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

By Vehmanen L.   Saarto T.   Elomaa I.   Makela P.   Valimaki M.   Blomqvist C.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2373-2378

Elsevier

Access to resources Recommend Favorite